Abstract:Hyperlipidemia plays an important role in the progression of kidney injury, likely due to renal lipotoxicity. The purpose of the present study was to investigate whether atrial natriuretic peptide (ANP) prevented lipid‐induced injury through inhibiting endoplasmic reticulum (ER) stress and apoptosis in the kidney. In human proximal tubule HK2 cells, saturated fatty acid palmitic acid (PA) treatment (0.4mM) for 24h markedly increased protein abundance of two ER stress makers BiP (3.7‐folds of controls) and CHOP (5.2‐folds of controls), which was associated with upregulated cleaved‐caspase 3 expression (3.2‐folds of controls) and decreased ratio of Bcl2/Bax (0.76‐folds of controls), two markers of apoptosis. ANP treatment (10pM) markedly decreased protein abundance of BiP (2.8‐folds of controls), CHOP (3.7‐folds of controls), and cleaved‐caspase 3 (1.7‐folds of controls), and increased the ratio of Bcl2/Bax (1.2‐folds of controls) in HK2 cells treated by PA. Co‐treatment with ANP and LBQ657, a neprilysin inhibitor preventing hydrolysis of ANP, showed better protective effects than ANP treatment alone in HK2 cells treated with PA. ANP is known to stimulate intracellular cGMP‐PKG signaling pathway, the role of cGMP and PKG in ANP‐induced protection after PA treatment in HK2 cells was thus investigated. Sildenafil, an inhibitor of phosphodiesterase‐5 (PDE5), and exogenous 8‐Br‐cGMP markedly suppressed PA‐induced ER stress and apoptosis, whereas KT‐5823, a selective cGMP‐dependent PKG inhibitor, blocked protection of ANP or cGMP in HK2 cells treated with PA. A synthesized, specific PDE5 inhibitor LW1646 showed slightly better prevention than sildenafil on PA‐induced HK2 cell injury. ANP attenuated PA‐induced upregulation of inositol 1,4,5‐triphate receptor (IP3R) that is involved in calcium efflux from ER to cytoplasm. ANP decreased PA‐induced intracellular calcium oscillation, prevented PA‐induced mitochondrial depolarization, and promoted mitochondrial biogenesis in HK2 cells. Compared with controls, in mice fed with high‐fat diet for 8wk, the protein expression of BiP and CHOP in the kidney cortex showed 2.8‐fold and 2.3‐fold increases, respectively, which was markedly prevented by sildenafil (15mg/kg·BW/day, gavage). In conclusion, these findings demonstrated that ANP inhibited lipid‐induced ER stress and apoptosis, likely via activating the cGMP‐PKG signaling pathway and maintaining mitochondrial function, it may be a potentially therapeutic target for lipid‐induced kidney injury.

A Peptide from Yak Ameliorates Hypoxia-Induced Kidney Injury by Inhibiting Inflammation and Apoptosis Via Nrf2 Pathway

Nanoparticle-mediated Klotho Gene Therapy Prevents Acute Kidney Injury to Chronic Kidney Disease Transition Through Regulating PPARα Signaling in Renal Tubular Epithelial Cells

An active peptide from yak inhibits hypoxia-induced lung injury via suppressing VEGF/MAPK/inflammatory signaling

Hypoxia-inducible factor prolyl hydroxylase inhibitor alleviates heatstroke-induced acute kidney injury by activating BNIP3-mediated mitophagy

Hypoxia-inducible Factor-1Α Dependent Pathways Mediate the Renoprotective Role of Acetazolamide Against Renal Ischemia-Reperfusion Injury.

Mild Hypoxia Enhances the Expression of HIF and VEGF and Triggers the Response to Injury in Rat Kidneys

CPUY192018, a Potent Inhibitor of the Keap1-Nrf2 Protein-Protein Interaction, Alleviates Renal Inflammation in Mice by Restricting Oxidative Stress and NF-κB Activation.

A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-β signaling

The novel peptide PEP-Z-2 potentially treats renal fibrosis in vivo and in vitro by regulating TGF-β/Smad/AKT/MAPK signaling

A Novel 14-Amino Acid Peptide from Yak Alleviates Kidney Damage in the Rat Model of Myocardial Ischemia-Reperfusion

Paeoniflorin alleviates hypoxia/reoxygenation injury in HK-2 cells by inhibiting apoptosis and repressing oxidative damage via Keap1/Nrf2/HO-1 pathway

Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against renal ischemia/reperfusion injury by inhibiting inflammation

HIF1α-BNIP3-mediated mitophagy protects against renal fibrosis by decreasing ROS and inhibiting activation of the NLRP3 inflammasome

A novel proteolysis-resistant cyclic helix B peptide ameliorates kidney ischemia reperfusion injury.

Helix B surface peptide administered after insult of ischemia reperfusion improved renal function, structure and apoptosis through beta common receptor/erythropoietin receptor and PI3K/Akt pathway in a murine model.

ZLN005 protects against ischemia-reperfusion-induced kidney injury by mitigating oxidative stress through the restoration of mitochondrial fatty acid oxidation

Cathelicidin PR-39 Peptide Inhibits Hypoxia/reperfusion-Induced Kidney Cell Apoptosis by Suppression of the Endoplasmic Reticulum-Stress Pathway.

Renoprotective Effect of the Recombinant Anti-IL-6R Fusion Proteins by Inhibiting JAK2/STAT3 Signaling Pathway in Diabetic Nephropathy

Molecular mechanisms and potential targets of lycopene for alleviating renal ischemia-reperfusion injury revealed by network pharmacology and animal experiments

Rapeseed protein-derived antioxidant peptide RAP alleviates renal fibrosis through MAPK/NF-κB signaling pathways in diabetic nephropathy.

Atrial Natriuretic Peptide Prevented Lipid-Induced Kidney Injuries by Inhibiting Endoplasmic Reticulum Stress